Peripheral Vascular

Showing 17–20 of 20 results

PTA Balloon Catheters Market Analysis | Europe | 2020-2026 | MedCore

Percutaneous transluminal angioplasty (PTA) balloon catheters can be used in two ways for the treatment of peripheral vascular lesions. One way is to expand the lumen of an obstructed blood vessel; this method is informally referred to as “plain old balloon angioplasty” (POBA). During POBA, the balloon catheter is inserted into the narrowed vascular region and expanded with water pressure to press the fatty deposits against the vessel walls.


Transcatheter Embolization Devices Market Analysis | Europe | 2020-2026 | MedCore

Transcatheter embolization is the practice of introducing material to within the vasculature to induce blood flow occlusions. Transcatheter embolization is effective for treating vessel malformations such as aneurysms, fistulae and bleeding. If left untreated, some of these arteriovenous malformations can ultimately lead to strokes. In addition, transcatheter embolization is an effective therapy for blocking blood flow to tumors or organs, thus starving the target tissues. Specialized particles, such as drug-coated and radiolabeled beads, are used for the targeted delivery of drugs and for radiation therapy, respectively.


Peripheral Vascular Devices Procedure Volume Analysis | Europe | 2020-2026 | MedPro

The full report suite on the European market for Peripheral Vascular (PV) devices includes peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion (CTO) devices, embolic protection devices (EPDs), stent-grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, diagnostic and interventional catheters, standard and hydrophilic guidewires, introducer sheaths, vascular closure devices (VCDs) and transcatheter embolization devices.


Atherectomy Device Market Analysis | United States | 2020-2026 | MedCore

Atherectomy is a procedure used for removing plaque deposits from arteries. They have traditionally been more effective in peripheral than coronary applications. The success of atherectomies has been driven by the limited performance of existing treatments. Often, a blockage is alleviated above the knee, only to have the blood flow deteriorate due to further bottlenecks below the knee. Failure to resolve these vascular limitations can result in critical limb ischemia, ulceration, limb pain or eventual amputation if left untreated.